Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model
- 1 January 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (1), 420-425
- https://doi.org/10.1182/blood-2004-06-2222
Abstract
Bone marrow-derived endothelial precursor cells incorporate into neovasculature and have been successfully used as vehicles for gene delivery to brain tumors. To determine whether systemically administered Sca1+ bone marrow cells labeled with superparamagnetic iron oxide nanoparticles can be detected by in vivo magnetic resonance imaging in a mouse brain tumor model, mouse Sca1+ cells were labeled in vitro with ferumoxides-poly-l-lysine complexes. Labeled or control cells were administered intravenously to glioma-bearing severe combined immunodeficient (SCID) mice. Magnetic resonance imaging (MRI) was performed during tumor growth. Mice that received labeled cells demonstrated hypointense regions within the tumor that evolved over time and developed a continuous dark hypointense ring at a consistent time point. This effect was not cleared by administration of a gadolinium contrast agent. Histology showed iron-labeled cells around the tumor rim in labeled mice, which expressed CD31 and von Willebrand factor, indicating the transplanted cells detected in the tumor have differentiated into endothelial-like cells. These results demonstrate that MRI can detect the incorporation of magnetically labeled bone marrow-derived precursor cells into tumor vasculature as part of ongoing angiogenesis and neovascularization. This technique can be used to directly identify neovasculature in vivo and to facilitate gene therapy by noninvasively monitoring these cells as gene delivery vectors. (Blood. 2005;105:420-425)Keywords
This publication has 23 references indexed in Scilit:
- Characterization of Biophysical and Metabolic Properties of Cells Labeled with Superparamagnetic Iron Oxide Nanoparticles and Transfection Agent for Cellular MR ImagingRadiology, 2003
- Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniquesTransplantation, 2003
- Clinically Applicable Labeling of Mammalian and Stem Cells by Combining Superparamagnetic Iron Oxides and Transfection AgentsRadiology, 2003
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003
- Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cellsNature Medicine, 2003
- Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectorsGene Therapy, 2003
- Magnetic Intracellular Labeling of Mammalian Cells by Combining (FDA-Approved) Superparamagnetic Iron Oxide MR Contrast Agents and Commonly Used Transfection AgentsAcademic Radiology, 2002
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthNature Medicine, 2001
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971